Real-time Stock quotes, portfolio, LIVE TV and more.
4.8 (0.61%)
4.9 (0.62%) 4.37 pm | 13 Dec 2010 | Source: CNBC-TV18
In an interview with CNBC-TV18’s Latha Venkatesh, Kamal K Sharma, MD, Lupin, spoke about the latest happenings in his company and sector....
2.40 pm | 29 Nov 2010 | Source: CNBC-TV18
The December launch of AllerNaze is delayed due to packaging issues, CFO of Lupin S Ramesh said. “We have postponed it indefinitely, but we could expe...
2.55 pm | 24 Sep 2010 | Source: Reuters
Indian pharma major Lupin Ltd expects continued growth in US sales this fiscal on its rising branded and generics business, a top official said late o...
10.14 am | 03 Sep 2010 | Source: CNBC-TV18
Lupin has got USFDA permission to seek approval for generic Lipitor, reports CNBC-TV18 . Lupin is proposing a capsule version of the drug as against t...
4.12 pm | 28 Jul 2010 | Source: Reuters
Pharma major Lupin expects to add six to 10 new US FDA approvals by the end of the 2011 fiscal to its present pipeline of 45 approvals, its managing d...
4.32 pm | 25 May 2010 | Source: Reuters
Pharma major Lupin Ltd has received US FDA approval for its losartan potassium and hydrochlorothiazide tablets, the drug regulator's website showed on...
1.17 pm | 22 May 2010 | Source: Moneycontrol.com
For heads of Finance of companies – the Chief Financial Officers – the changes have been radical. And that was what Moneycontrol.com's CFO Thought Lea...
2.04 pm | 20 Apr 2010 | Source: Reuters
Lupin Ltd said on Tuesday its unit has received US FDA approval for Imipramine Pamoate capsules, an abbreviated new drug application (ANDA)...
3.02 pm | 13 Apr 2010 | Source: Reuters
Indian mid-cap drug makers are expected to report robust quarterly results as rising sales in domestic and US markets would help them generate higher ...
7.07 pm | 26 Mar 2010 | Source: Moneycontrol.com
Lupin Limited has launched Hyalgan® (sodium hyaluronate), an osteoarthritis drug, available in the form of an injectable through leading orthopaedics ...
12.14 pm | 20 Jan 2010 | Source: Moneycontrol.com
CNBC-TV18 learns that Mumbai-based drug firm Lupin Pharmaceutical’s Mandideep facility has received a clearance from the United States Food and Drug A...